Meloxicam Capsules and Tezacaftor/ivacaftor and ivacaftor
Determining the interaction of Meloxicam Capsules and Tezacaftor/ivacaftor and ivacaftor and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Coadministration with ivacaftor may increase the plasma concentrations of drugs that are substrates of the CYP450 2C9 isoenzyme. The proposed mechanism, based on in vitro data, involves decreased metabolic clearance due to inhibition of CYP450 2C9 by ivacaftor. The clinical relevance is unknown. MANAGEMENT: Caution is advised when ivacaftor is used concurrently with drugs that are known CYP450 2C9 substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever ivacaftor is added to or withdrawn from therapy. References "Product Information. Kalydeco (ivacaftor)." Vertex Pharmaceuticals, Cambridge, MA. "Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor)." Vertex Pharmaceuticals, Cambridge, MA. "Product Information. Orkambi (ivacaftor-lumacaftor)." Vertex Pharmaceuticals, Cambridge, MA. "Product Information. Symdeko 4-Week (ivacaftor-tezacaftor)." Vertex Pharmaceuticals, Cambridge, MA. View all 4 references
Professional:MONITOR: Coadministration with ivacaftor may increase the plasma concentrations of drugs that are substrates of the CYP450 2C9 isoenzyme. The proposed mechanism, based on in vitro data, involves decreased metabolic clearance due to inhibition of CYP450 2C9 by ivacaftor. The clinical relevance is unknown.
MANAGEMENT: Caution is advised when ivacaftor is used concurrently with drugs that are known CYP450 2C9 substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever ivacaftor is added to or withdrawn from therapy.
- "Product Information. Kalydeco (ivacaftor)." Vertex Pharmaceuticals, Cambridge, MA.
- "Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor)." Vertex Pharmaceuticals, Cambridge, MA.
- "Product Information. Orkambi (ivacaftor-lumacaftor)." Vertex Pharmaceuticals, Cambridge, MA.
- "Product Information. Symdeko 4-Week (ivacaftor-tezacaftor)." Vertex Pharmaceuticals, Cambridge, MA.
Generic Name: meloxicam
Brand name: Mobic, Vivlodex, Meloxicam Comfort Pac [DSC], Qmiiz ODT
Synonyms: Meloxicam
Generic Name: ivacaftor / tezacaftor
Brand name: Symdeko, Symdeko 4-Week
Synonyms: Tezacaftor/ivacaftor and ivacaftor (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Meloxicam Capsules-TGQ 30PSE/3BRM/15DM
- Meloxicam Capsules-TGQ 7.5PEH/4BRM/15DM
- Meloxicam Capsules-TGT First Aid Antibiotic
- Meloxicam Capsules-TGT First Aid Cleansing
- Meloxicam Capsules-TH Antibiotic + Pain Relief
- Meloxicam Capsules-Thalidomide
- Tezacaftor/ivacaftor and ivacaftor-Meloxicam Oral Suspension
- Tezacaftor/ivacaftor and ivacaftor-Meloxicam Orally-Disintegrating Tablets
- Tezacaftor/ivacaftor and ivacaftor-Meloxicam Suspension
- Tezacaftor/ivacaftor and ivacaftor-Meloxicam Tablets
- Tezacaftor/ivacaftor and ivacaftor-Melphalan
- Tezacaftor/ivacaftor and ivacaftor-Melphalan Injection